![](https://static.lse.co.uk/images/news-logos/alliance-news-logo.png)
Hikma adds scale to US injectables business with Xellia acquisition
(Alliance News) - Hikma Pharmaceuticals PLC on Monday bolstered its US and injectables business with the purchase of assets from Denmark's Xellia Phar...
Fri, 08th Nov 2013 07:45
(Alliance News) - Hikma Pharmaceuticals PLC on Monday bolstered its US and injectables business with the purchase of assets from Denmark's Xellia Phar...
(Alliance News) - London's FTSE 100 is called to open solidly higher on Monday, recovering some poise after a tricky week, with eyes turning to the Ba...
(Sharecast News) - Hikma Pharmaceuticals said on Monday that it has agreed to buy parts of Xellia Pharmaceuticals, a Copenhagen-based specialty compan...
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:
(Sharecast News) - Citi lifted its price target on Hikma Pharmaceuticals on Tuesday to 2,845p from 2,770p as it said IQVIA April data highlighted "hea...